Peripherally Inserted Central Catheters Market - By Product (Power Injected PICC, Conventional PICC, Neonatal PICC), Lumen (Single, Double, Multiple), Application, (Chemotherapy, Long-term IV Infusion, Parenteral Nutrition) End-Use & Forecast, 2024 - 2032
Report ID: GMI9331
|
Published Date: May 2024
|
Report Format: PDF
Download Free PDF
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 12
Tables & Figures: 151
Countries covered: 23
Pages: 100
Download Free PDF

Peripherally Inserted Central Catheters Market
Get a free sample of this reportGet a free sample of this report Peripherally Inserted Central Catheters Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Peripherally Inserted Central Catheters Market Size
Peripherally Inserted Central Catheters Market size was valued at around USD 1.3 billion in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032. The increasing prevalence of infectious diseases and rising incidence of chronic conditions worldwide have propelled the demand for peripherally inserted central catheters (PICCs) globally.
Infectious diseases such as sepsis, pneumonia, and bloodstream infections often require prolonged intravenous therapy, necessitating the use of PICCs for reliable and long-term venous access. Additionally, the growing burden of chronic conditions such as cancer, kidney disease, and autoimmune disorders has led to an increase in the need for PICCs for chemotherapy, dialysis, and other treatments that require frequent or continuous infusion of medications and fluids.
For instance, according to Centers for Disease Control and Prevention (CDC), in 2019, there were 201,092 deaths in the U.S. involving sepsis, with three-fourths of those deaths occurring among persons aged 65 and over. These statistics underscore the growing demand for PICCs as a vital tool in managing both infectious diseases and chronic conditions, driving market growth for these catheters on a global scale.
Peripherally inserted central catheters (PICCs) are long, flexible tubes inserted into a peripheral vein, usually in the arm, and threaded through the vein until the tip reaches a large central vein near the heart, such as the superior vena cava or the inferior vena cava. PICCs are used to administer medications, fluids, blood products, or nutrients over an extended period, typically weeks to months, and can also be used for blood draws and to monitor central venous pressure.
Peripherally Inserted Central Catheters Market Trends
Advancements in peripherally inserted central catheters (PICCs) have been driven by the need for safer, more reliable, and patient-friendly intravenous access.
Peripherally Inserted Central Catheters Market Analysis
Based on product, the market is categorized into power injected PICC, conventional PICC, and neonatal PICC. The power injected PICC segment dominated the market and was valued at USD 599.2 million in revenue in 2023.
Based on lumen, the peripherally inserted central catheters market is categorized into single, double, and multiple. The double lumen segment dominated the market, with the revenue of around USD 632.3 million in revenue in 2023.
Based on application, the peripherally inserted central catheters market is categorized into chemotherapy, long-term IV infusion, parenteral nutrition, blood transfusion, and other applications. The long-term IV infusion segment dominated the market, with the revenue of around USD 426.4 million in revenue in 2023.
Based on end-use, the peripherally inserted central catheters market is categorized into hospitals, ambulatory surgical centers, home-care centers, and other end-users. The hospitals are segment held the dominant position in the market and is anticipated to reach around USD 1.2 billion in 2032.
North America peripherally inserted central catheters market accounted for USD 447 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
U.S. peripherally inserted central catheters market holds a dominant position with the market share of 92.5% in 2023.
Germany peripherally inserted central catheters market is anticipated to witness notable growth during 2024-2032.
China may experience a high growth potential in the peripherally inserted central catheters market.
Peripherally Inserted Central Catheters Market Share
The peripherally inserted central catheters (PICCs) industry is competitive in nature, as large multinational corporations and smaller firms compete for dominance. Key players continuously innovate to develop novel PICCs that offer enhanced efficiency, comfort, and cost-effectiveness. This focus on innovation drives competitiveness, ensuring that PICC technology remains at the forefront of medical advancements. Manufacturers aim to expand their market share by introducing new materials, formulations, and delivery systems to meet the growing demand for advanced PICCs, ultimately improving patient outcomes and quality of life.
Peripherally Inserted Central Catheters Companies
Some of the eminent market participants operating in the peripherally inserted central catheters industry include:
Peripherally Inserted Central Catheters Industry News:
Peripherally inserted central catheters market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
By Lumen
By Applications
By end-use
The above information is provided for the following regions and countries: